Global Cannabinoid Derived Pharmaceutical Supply, Demand and Key Producers, 2023-2029

Global Cannabinoid Derived Pharmaceutical Supply, Demand and Key Producers, 2023-2029

The global Cannabinoid Derived Pharmaceutical market size is expected to reach $ 1994.1 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).

This report studies the global Cannabinoid Derived Pharmaceutical production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cannabinoid Derived Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cannabinoid Derived Pharmaceutical that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cannabinoid Derived Pharmaceutical total production and demand, 2018-2029, (K Units)

Global Cannabinoid Derived Pharmaceutical total production value, 2018-2029, (USD Million)

Global Cannabinoid Derived Pharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Cannabinoid Derived Pharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Cannabinoid Derived Pharmaceutical domestic production, consumption, key domestic manufacturers and share

Global Cannabinoid Derived Pharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Cannabinoid Derived Pharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Cannabinoid Derived Pharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Cannabinoid Derived Pharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cara Therapeutics Inc, Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc, Echo Pharmaceuticals, Gw Pharmaceuticals, Inmed Pharmaceuticals, Insys Therapeutics Inc, Larapharm and Mgc Pharmaceuticals Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cannabinoid Derived Pharmaceutical market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cannabinoid Derived Pharmaceutical Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cannabinoid Derived Pharmaceutical Market, Segmentation by Type
Cannabinoid Receptor Type 1 (CB1)
Cannabinoid Receptor Type 2 (CB2)
Others

Global Cannabinoid Derived Pharmaceutical Market, Segmentation by Application
Epilepsy
Migraine
Multiple Sclerosis
Others

Companies Profiled:
Cara Therapeutics Inc
Arena Pharmaceuticals
Cannabics Pharmaceuticals Inc
Echo Pharmaceuticals
Gw Pharmaceuticals
Inmed Pharmaceuticals
Insys Therapeutics Inc
Larapharm
Mgc Pharmaceuticals Ltd
One World Cannabis
Orpheus Medica
Receptor Life Sciences
Respirerx Pharmaceuticals
Tetra Bio-Pharma
Cardiol Therapeutics
United Cannabis Corporation
Zynerba Pharmaceuticals

Key Questions Answered

1. How big is the global Cannabinoid Derived Pharmaceutical market?

2. What is the demand of the global Cannabinoid Derived Pharmaceutical market?

3. What is the year over year growth of the global Cannabinoid Derived Pharmaceutical market?

4. What is the production and production value of the global Cannabinoid Derived Pharmaceutical market?

5. Who are the key producers in the global Cannabinoid Derived Pharmaceutical market?

6. What are the growth factors driving the market demand?